Pharmacosmos A/S vs. American Regent, Inc.
Explore the PTAB proceeding IPR2019-01142 filed by Pharmacosmos A/S on 2019-06-14. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2019-01142
Filing Date
2019-06-14
Accorded Filing Date
2019-06-19
Institution Decision Date
2019-12-18
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
β
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Pharmacosmos A/S
Represented By
Oelke, JeffreyPatent Owner / Respondent
American Regent, Inc.
Represented By
Quillin, Georgeet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34781 | Livia Boyadjian | +1 718-224-9157 |
| 39492 | William Schmidt | +1 631-656-9818 |
| 42796 | Leo Lenna | +1 631-656-9818 |
| 44349 | Peter Sorell | +1 631-656-9818 |
| 47046 | Martha Rumore | +1 631-656-9818 |
| 62137 | Erik Zarkowsky | +1 516-228-8484 |
| 73588 | Marshall Yeh | +1 631-656-9818 |
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 13 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 8,431,549 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2013023056 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,895,612 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,478,450 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,433,091 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,406,656 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,478,502 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,344,568 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,364,260 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 12,329,772 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2025033219 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 75,711,906 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 7,754,702 B2 | US Continuation / Sibling | View Official Patent → |
Pharmacosmos A/S et al. v. American Regent, Inc.
Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc.
Pharmacosmos A/S v. LUITPOLD PHARMACEUTICALS, INC.